Although clinicopathologically these FGFR2 translocation bearing ICC tumors are indistinguishable from the rest of the cohort, they are invariably of the mass-forming type originated from the small bile duct. This evidence concerns the gene FGFR2 and intrahepatic cholangiocarcinoma.